🔗 Visit the ClinicalTrials.gov page for NCT02359019
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes? | J Thorac Oncol | 2016 | 1.03 |
| 2 | Advances in immunotherapy for treatment of lung cancer. | Cancer Biol Med | 2015 | 0.95 |
| 3 | Immunotherapy for lung cancer: advances and prospects. | Am J Clin Exp Immunol | 2016 | 0.89 |
| 4 | Cellular and molecular biology of small cell lung cancer: an overview. | Transl Lung Cancer Res | 2016 | 0.79 |
| 5 | Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer. | Transl Lung Cancer Res | 2015 | 0.78 |
| 6 | The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. | Oncologist | 2016 | 0.78 |
| 7 | Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel? | ESMO Open | 2016 | 0.77 |
| 8 | Targeted drugs in small-cell lung cancer. | Transl Lung Cancer Res | 2016 | 0.77 |